Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis

被引:53
|
作者
Alcázar, A
Regidor, I
Masjuan, J
Salinas, M
Alvarez-Cermeño, JC
机构
[1] Hosp Ramon & Cajal, Serv Neurol, E-28034 Madrid, Spain
[2] Hosp Ramon & Cajal, Serv Bioquim Invest, E-28034 Madrid, Spain
[3] Univ Alcala de Henares, Dept Med, Alcala De Henares, Spain
关键词
apoptosis; axonal damage; cerebrospinal fluid; cultured neurons; multiple sclerosis;
D O I
10.1016/S0165-5728(99)00225-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The importance of axonal damage in multiple sclerosis (MS) has been recently stressed in proton magnetic resonance spectroscopy and pathological studies, but the exact mechanism producing this damage is unknown. The aim of our study was to ascertain whether soluble mediators present in the cerebrospinal fluid (CSF) of patients with relapsing-remitting MS could induce neuron injury in culture. Different biochemical and cytochemical parameters were determined in primary embryonal rat neuron cultures following 8 days of exposure to CSF. Cytotoxic activity was evaluated with a blue formazan production colorimetric assay. Morphological and immunocytochemical studies performed with antibodies against beta-tubulin revealed neuritic fragmentation, axonal damage and cellular shrinkage indicating apoptosis, Detection of apoptosis was carried out using the fluorescent DNA-binding dye Hoechst 33342, as well as by a Terminal deoxynucleotidyl transferase-mediated dUTP Nick End-Labeling assay. We observed that soluble factors in CSF from patients with "aggressive" MS i.e, those with poor recovery after relapses, induced neurite breakdown and neuronal apoptosis in cultures. Neuron injury is not related with blood-brain barrier dysfunction nor with IgG index. Interestingly, CSF from patients with "non-aggressive" MS i.e., relapsing-remitting patients with a good recovery after relapses, did not induce any damage. In conclusion, we report that CSF from patients with aggressive MS bears soluble mediators that induce axonal damage and apoptosis of neurons in culture. These mediators can be present during the first attack of the disease, and the neuronal damage caused could be related to the functional deficit of these MS patients. (C) 2000 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:58 / 67
页数:10
相关论文
共 50 条
  • [21] Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: A correlation with clinical activity.
    Carrieri, PB
    Provitera, V
    De Rosa, T
    Tartaglia, G
    Gorga, F
    Perrella, O
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1998, 20 (03) : 373 - 382
  • [22] Tau protein in cerebrospinal fluid:: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis
    Martínez-Yélamos, A
    Saiz, A
    Bas, J
    Hernandez, JJ
    Graus, F
    Arbizu, T
    NEUROSCIENCE LETTERS, 2004, 363 (01) : 14 - 17
  • [23] Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis
    Novakova, Lenka
    Axelsson, Markus
    Khademi, Mohsen
    Zetterberg, Henrik
    Blennow, Kaj
    Malmestrom, Clas
    Piehl, Fredrik
    Olsson, Tomas
    Lycke, Jan
    JOURNAL OF NEUROCHEMISTRY, 2017, 141 (02) : 296 - 304
  • [24] Cerebrospinal fluid sulfatide isoforms lack diagnostic utility in separating progressive from relapsing-remitting multiple sclerosis
    Novakova, Lenka
    Henricsson, Marcus
    Bjornson, Elias
    Axelsson, Markus
    Boren, Jan
    Rosenstein, Igal
    Lycke, Jan
    Cardell, Susanna L.
    Blomqvist, Maria
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 74
  • [25] Subclinical atherosclerosis in patients with relapsing-remitting multiple sclerosis
    Omerzu, Tomaz
    Magdic, Jozef
    Hojs, Radovan
    Potocnik, Uros
    Gorenjak, Mario
    Fabjan, Tanja Hojs
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 (1-2) : 40 - 47
  • [26] Screening for dysphagia in patients with relapsing-remitting multiple sclerosis
    Kocica, Jan
    Lasotova, Nadezda
    Kolcava, Jan
    Svobodova, Monika
    Hladikova, Magdalena
    Stourac, Pavel
    Bednarik, Josef
    Vlckova, Eva
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 83
  • [27] Neurovascular coupling in patients with relapsing-remitting multiple sclerosis
    Uzuner, Gulnur Tekgol
    Uzuner, Nevzat
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2016, 146 : 24 - 28
  • [28] Comorbidity in in patients with relapsing-remitting multiple sclerosis.
    Somilo, O., V
    Makarov, S. O.
    Kalbus, O., I
    MEDICNI PERSPEKTIVI, 2024, 29 (03): : 137 - 143
  • [29] Cognitive impairment in patients with relapsing-remitting multiple sclerosis
    Mendes, M. F.
    Balsimelli, S.
    Tilbery, C. P.
    MULTIPLE SCLEROSIS, 2006, 12 : S142 - S142
  • [30] Cognitive impairment in relapsing-remitting multiple sclerosis patients
    Altinkaya, A.
    Ozcan, E.
    Yandim-Kuscu, D.
    Kurt, E.
    Bingol, A.
    Kirbas, D.
    Topcular, B.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 406 - 406